Galapagos NV
GLPG
#4541
Rank
S$2.79 B
Marketcap
S$42.35
Share price
0.15%
Change (1 day)
13.82%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: S$2.79 Billion

As of December 2025 Galapagos NV has a market cap of S$2.79 Billion. This makes Galapagos NV the world's 4541th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025S$2.79 B14.13%
2024S$2.44 B-30.88%
2023S$3.53 B-9.68%
2022S$3.91 B-20.69%
2021S$4.93 B-42.35%
2020S$8.56 B-52.97%
2019S$18.21 B165.62%
2018S$6.85 B6.75%
2017S$6.42 B48.94%
2016S$4.31 B23.69%
2015S$3.48 B362.39%
2014S$0.75 B-5.03%
2013S$0.79 B14.9%
2012S$0.69 B49.61%
2011S$0.46 B-15.71%
2010S$0.54 B53.14%
2009S$0.35 B143.5%
2008S$0.14 B

End of Day market cap according to different sources

On Dec 25th, 2025 the market cap of Galapagos NV was reported to be:

S$2.79 Billion
by Nasdaq info icon info icon
S$2.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
S$367.99 B 13,085.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$642.67 B 22,927.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$150.41 B 5,289.54%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$521.61 B 18,589.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S$0.14 B-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$278.87 B 9,892.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$46.74 B 1,575.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$127.20 B 4,457.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$341.34 B 12,130.72%๐Ÿ‡บ๐Ÿ‡ธ USA